AP NEWS
Click to copy
Press release content from Business Wire. The AP news staff was not involved in its creation.
Click to copy
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Healthcare Licensing Analytical Report 2019 with Focus on Immunotherapy - ResearchAndMarkets.com

September 10, 2019

DUBLIN--(BUSINESS WIRE)--Sep 10, 2019--

The “Analytical Report for Healthcare Licensing with Focus on Immunotherapy” report has been added to ResearchAndMarkets.com’s offering.

Immunotherapy has become an established pillar of cancer treatment improving the prognosis of many patients with a broad variety of hematological and solid malignancies. This report presents an in-depth study of licensing deals in the area of immunotherapy. 160+ licensing news with a focus on Immunotherapy, during January 1, 2019, to August 31, 2019, are reported and analyzed to provide a snapshot view of the current business trends.

Analytical data coverage:

User benefits:

Key analysis in the report:

Report useful to:

Key Topics Covered:

Introduction

Research Design

Chapter 1: Analysis of healthcare inventions with focus on Immunotherapy licensed during the past 8 months

1.1 Number of licensing deals with a focus on Immunotherapy

1.2 Countries with most licensing deals with a focus on Immunotherapy

1.3 Healthcare sub-sectors with most licensing deals with a focus on Immunotherapy

1.4 Market capitalization groups with most licensing deals with a focus on Immunotherapy

1.5 Medicine groups with most licensing deals with a focus on Immunotherapy

1.6 Leading companies with most licensing deals with a focus on Immunotherapy

1.7 Licensing payment arrangements most followed in licensing deals with a focus on Immunotherapy

Chapter 2: Key licensing deals with a focus on Immunotherapy during the past 8 months - By type of licensing deal

Chapter 3: Global healthcare inventions with focus on Immunotherapy licensed during the past 8 months - By region and company name

Chapter 4: Summary and conclusions

Appendices

Appendix 1 List of companies/institutes covered

a) By region, country and company name

b) By sub-industry, country and company name

c) By market capitalization group, country and company name

d) By medicine group, country and company name

e) By terms of payment, country and company name

Appendix 2 List of non-listed companies covered - By country and company name

Appendix 3 List of not-for-profit institutes covered - By country and institute name

For more information about this report visit https://www.researchandmarkets.com/r/c2lhy9

View source version on businesswire.com:https://www.businesswire.com/news/home/20190910005780/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: GENETICS HEALTH ONCOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 09/10/2019 10:45 AM/DISC: 09/10/2019 10:45 AM

http://www.businesswire.com/news/home/20190910005780/en

All contents © copyright 2019 The Associated Press. All rights reserved.